The diagnostic and clinicopathological value of Trefoil Factor 3 in patients with gastric cancer: a systematic review and meta-analysis.

Conclusion TFF3 may be a promising biomarker for GC, and the TFF3 expression is likely to be involved in the invasion, metastasis, and differentiation of GC, which has a potential function to access the clinicopathological significance of GC in clinical practices.
PMID: 33401971 [PubMed - as supplied by publisher]

Source: Biomarkers - January 7, 2021 Category: Research Tags: Biomarkers Source Type: research